Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMF vs Cyclophosphamide in Pediatric Lupus Nephritis
NCT05495893Phase 4Unknown
- Sponsor
- The Second Xiangya Hospital
- Start
- Jul 2022
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil in lupus nephritis (LN), sponsored by The Second Xiangya Hospital. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT05495893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05495893.